Kilian Reber

Person
Mentions
4
Relationships
2
Events
0
Documents
2

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.
2 total relationships
Connected Entity Relationship Type
Strength (mentions)
Documents Actions
person Michael Bolliger
Business associate
5
1
View
organization UBS
Employee
5
1
View
No events found for this entity.

HOUSE_OVERSIGHT_025275.jpg

A UBS financial presentation slide dated late October 2012 providing analysis on Emerging Market (EM) bonds. The document advises a neutral preference but favors EM corporate bonds over sovereigns, detailing spread targets, scenarios, and upcoming central bank dates. It includes the Bates stamp 'HOUSE_OVERSIGHT_025275', indicating it was produced as part of a congressional investigation, likely regarding UBS's financial dealings.

Financial research report / presentation slide
2025-11-19

HOUSE_OVERSIGHT_024163.jpg

This document is a UBS investment outlook slide dated June 27, 2012, focusing on Emerging Market (EM) bonds with a recommendation to 'overweight.' It provides tactical and strategic advice, analyzing positive and negative economic scenarios, and lists specific upcoming dates for monetary policy announcements in various countries. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it was part of a document production for a congressional investigation.

Financial report / investment presentation slide
2025-11-19
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity